Who owns CHEMOMAB THERAPEUTICS LTD SPONSORED ADS?

Tip: Access positions for across all investors

Analyze quarterly positions in Chemomab Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Chemomab Therapeutics stock

Who bought or sold CHEMOMAB THERAPEUTICS LTD SPONSORED ADS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Citadel Advisors 95k $154k 49% Jun 2026
 View chart
ADAR1 Capital Management 80k $130k 0% Jun 2026
 View chart
Kestra Private Wealth Services 77k $92k 25% Sep 2026
 View chart
Ikarian Capital 52k $84k 0% Jun 2026
 View chart
Rhumbline Advisers 31k $50k 66% Jun 2026
 View chart
Intl Fcstone 19k $30k 100% Sep 2026
 View chart
XTX Topco 16k $26k -14% Jun 2026
 View chart
Philadelphia Investment Partners 15k $24k 83% Jun 2026
 View chart
SmartHarvest Portfolios 13k $16k 100% Sep 2026
 View chart
GAMMA Investing 9.2k $11k 94% Sep 2026
 View chart
Bnp Paribas Arbitrage, Snc 6.8k $11k -19% Jun 2026
 View chart
SBI Securities 30.00 $36.000000 -12% Sep 2026
 View chart
Caitong International Asset Management 17.00 $20.000500 112% Sep 2026
 View chart

Who sold out of Chemomab Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Lido Advisors Jun 2026 14k $23k
Susquehanna International Mar 2026 14k $21k